These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 11177478)

  • 1. Safety and efficacy of imiquimod 5% cream in the treatment of penile genital warts in uncircumcised men when applied three times weekly or once per day.
    Gollnick H; Barasso R; Jappe U; Ward K; Eul A; Carey-Yard M; Milde K
    Int J STD AIDS; 2001 Jan; 12(1):22-8. PubMed ID: 11177478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imiquimod 5% cream is an acceptable treatment option for external anogenital warts in uncircumcised males.
    Maw RD; Kinghorn GR; Bowman CA; Goh BT; Nayagam AT; Nathan M
    J Eur Acad Dermatol Venereol; 2002 Jan; 16(1):58-62. PubMed ID: 11952292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of external genital warts in men using 5% imiquimod cream applied three times a week, once daily, twice daily, or three times a day.
    Fife KH; Ferenczy A; Douglas JM; Brown DR; Smith M; Owens ML;
    Sex Transm Dis; 2001 Apr; 28(4):226-31. PubMed ID: 11318254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety, efficacy & recurrence rates of imiquimod cream 5% for treatment of anogenital warts.
    Diamantis ML; Bartlett BL; Tyring SK
    Skin Therapy Lett; 2009 Jun; 14(5):1-3, 5. PubMed ID: 19609471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of external genital warts in men with imiquimod 2% in cream. A placebo-controlled, double-blind study.
    Syed TA; Hadi SM; Qureshi ZA; Ali SM; Kwah MS
    J Infect; 2000 Sep; 41(2):148-51. PubMed ID: 11023759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open-label phase II pilot study investigating the optimal duration of imiquimod 5% cream for the treatment of external genital warts in women.
    Garland SM; Waddell R; Mindel A; Denham IM; McCloskey JC
    Int J STD AIDS; 2006 Jul; 17(7):448-52. PubMed ID: 16820073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical imiquimod: a review of its use in genital warts.
    Perry CM; Lamb HM
    Drugs; 1999 Aug; 58(2):375-90. PubMed ID: 10473026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.
    Edwards L; Ferenczy A; Eron L; Baker D; Owens ML; Fox TL; Hougham AJ; Schmitt KA
    Arch Dermatol; 1998 Jan; 134(1):25-30. PubMed ID: 9449906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of genital warts with an immune-response modifier (imiquimod).
    Beutner KR; Spruance SL; Hougham AJ; Fox TL; Owens ML; Douglas JM
    J Am Acad Dermatol; 1998 Feb; 38(2 Pt 1):230-9. PubMed ID: 9486679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts.
    Beutner KR; Tyring SK; Trofatter KF; Douglas JM; Spruance S; Owens ML; Fox TL; Hougham AJ; Schmitt KA
    Antimicrob Agents Chemother; 1998 Apr; 42(4):789-94. PubMed ID: 9559784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal frequency of imiquimod (aldara) 5% cream for the treatment of external genital warts in immunocompetent adults: a meta-analysis.
    Gotovtseva EP; Kapadia AS; Smolensky MH; Lairson DR
    Sex Transm Dis; 2008 Apr; 35(4):346-51. PubMed ID: 18360317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of imiquimod in anogenital warts from HIV-positive men.
    Herrera S; Correa LA; Wolff JC; Gaviria A; Tyring SK; Sanclemente G
    J Clin Virol; 2007 Jul; 39(3):210-4. PubMed ID: 17513167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical imiquimod 5% cream as an effective treatment for external genital and perianal warts in different patient populations.
    Sauder DN; Skinner RB; Fox TL; Owens ML
    Sex Transm Dis; 2003 Feb; 30(2):124-8. PubMed ID: 12567169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of female genital warts with an analog of imiquimod 2% in cream: a randomized, double-blind, placebo-controlled study.
    Syed TA; Ahmadpour OA; Ahmad SA; Ahmad SH
    J Dermatol; 1998 Jul; 25(7):429-33. PubMed ID: 9714974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imiquimod in clinical practice.
    Edwards L
    Australas J Dermatol; 1998 Nov; 39 Suppl 1():S14-6. PubMed ID: 9842096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of severe eczema following use of imiquimod 5% cream.
    Taylor CL; Maslen M; Kapembwa M
    Sex Transm Infect; 2006 Jun; 82(3):227-8. PubMed ID: 16731674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of imiquimod 3.75% cream in the treatment of external genital warts.
    Berman B; Wolf J
    Skin Therapy Lett; 2012 Apr; 17(4):5-7. PubMed ID: 22491804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imiquimod cream 5% for recalcitrant cutaneous warts in immunosuppressed individuals.
    Harwood CA; Perrett CM; Brown VL; Leigh IM; McGregor JM; Proby CM
    Br J Dermatol; 2005 Jan; 152(1):122-9. PubMed ID: 15656812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of adjuvant imiquimod 5% cream on sustained clearance of anogenital warts following laser treatment.
    Hoyme UB; Hagedorn M; Schindler AE; Schneede P; Hopfenmüller W; Schorn K; Eul A
    Infect Dis Obstet Gynecol; 2002; 10(2):79-88. PubMed ID: 12530484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical imiquimod cream 5% for resistant perianal warts in a renal transplant patient.
    Gayed SL
    Int J STD AIDS; 2002 May; 13(5):349-51. PubMed ID: 11972940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.